Purchase Order N3239824P0009
Award Date
6/1/24
Potential Completion Date
4/11/25
Potential Value
$4.9K
Federal Agency
Bureau of Medicine and Surgery
Awardee
Qiagen, LLC
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20910, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm-fixed-price purchase order contract awarded by the Bureau of Medicine and Surgery, a component of the U.S. Department of Defense, to Qiagen, LLC for the delivery of EZ1 DSP VIRUS KITS. The contract has a ceiling value of $7,845.61 and a completion date of December 1, 2017. Qiagen, LLC is a subsidiary of the multinational biotechnology company Qiagen N.V., which provides sample and assay technologies to support federal agencies' biomedical research, public health, law...
This $83,927.20 firm fixed-price purchase order was awarded by the Defense Health Agency (DHA), a component of the U.S. Department of Defense, to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. The contract is for the delivery of EZ1 ADVANCED XL equipment, which is used for DNA/RNA extraction and sample preparation. This purchase order is not associated with a set-aside program. Qiagen has a history of providing specialized products and services to support...
This is a firm fixed-price purchase order contract awarded by the Defense Health Agency (DHA) to Qiagen, LLC for the delivery of EZ1 DNA BLOOD 350 UL KITS (48). The contract has a ceiling value of $20,961.12 and a completion date of September 29, 2019. Qiagen, LLC is a division of the international provider of sample and assay technologies, Qiagen N.V. Qiagen has provided a range of products and services to support federal agencies' biomedical research, public health, law enforcement, and...
This is a firm fixed-price purchase order awarded by the Bureau of Medicine and Surgery, a defense agency, to Qiagen, LLC, a foreign-owned for-profit manufacturer, for $10,026.00 to provide preventative maintenance services for two EZ1 Advanced XL laboratory instruments located at the Naval Medical Research Command's Infectious Diseases Diagnostic Laboratory. The contract has a 12-month period of performance from April 12, 2025 to April 11, 2026 and was awarded without any set-aside designation....
This is a firm fixed-price purchase order awarded by the U.S. Navy Bureau of Medicine and Surgery to Qiagen, LLC, a division of the international diagnostics company Qiagen N.V. The $10,546.00 contract is for QIAXTRACTOR/QIACUBE HT SERVICE, which are likely equipment maintenance and service support for Qiagen's sample processing and diagnostic systems used in federal biomedical research, public health, and healthcare programs. Qiagen has a history of providing a range of products and services to...
This is a federal purchase order contract award to Qiagen, LLC, a division of Qiagen N.V., by the U.S. Department of Defense's Bureau of Medicine and Surgery. The contract is for the purchase of QIAAMP DNA BLOOD KIT, 200UL and EZ1 DNA TISSUE KIT, 200UL at a firm fixed price of $102,022.09. The award date was July 27, 2015, and the ultimate completion date is August 1, 2016. This contract has no set-aside designation. Qiagen is an international provider of sample and assay technologies that has...
This federal contract award was issued by the Bureau of Medicine and Surgery, a component of the U.S. Department of Defense, to Qiagen, LLC, a subsidiary of the biotechnology company Qiagen N.V. The $1,897 firm fixed-price purchase order is for labor hours (CLIN 9236439) with a period of performance through September 29, 2019. Qiagen is an established provider of sample and assay technologies supporting federal agencies' biomedical research, public health, law enforcement, and healthcare...
This firm fixed-price purchase order contract was awarded by the Defense Health Agency to Qiagen, LLC, a foreign-owned, for-profit manufacturer of molecular diagnostics and life sciences products. The $211,853.58 contract is for QCII ONE PRECUR 301-600 TESTING and has a performance period ending on May 31, 2027. Qiagen, LLC is a subsidiary of the multinational biotechnology company Qiagen N.V., which has a substantial portfolio of federal contracts and grants for providing specialized equipment,...
This firm fixed-price purchase order for $14,943.24 was awarded by the Defense Health Agency to Qiagen, LLC, a division of Qiagen N.V., to provide maintenance services for three QIAGEN EZ1 Advanced XL automated nucleic acid systems. The contract has an ultimate completion date of September 29, 2025. This award is not associated with a set-aside program. Qiagen is an international provider of sample and assay technologies for molecular diagnostics, applied testing, pharma, and academics, and...
The Department of the Navy Bureau of Medicine and Surgery awarded a firm-fixed-price purchase order contract to Qiagen, LLC, a division of Qiagen N.V., an international provider of sample and assay technologies. The $5,356 contract has a period of performance through April 11, 2025 and does not have a set-aside designation. Qiagen is a manufacturer of goods and has provided a range of products and services to support federal agencies' biomedical research, public health, law enforcement, and...